Buy AOD 9604 5 mg + bacteriostatic water 3 ml

€31.23

AOD-9604, 5 mg, with 3 mL bacteriostatic water, is a disulphide-containing 16-residue peptide for analytical and in vitro laboratory research. Pharma Research .eu provides documented European supply subject to lot-specific purity and structural verification.

Category:
Description

Buy AOD-9604, 5 mg + Bacteriostatic Water, 3 mL, for Advanced Laboratory Research in Europe

AOD-9604 is a synthetic 16-residue peptide analogue derived from the C-terminal region of human growth hormone. It contains an N-terminal tyrosine and an intramolecular disulphide bridge between two cysteine residues. The commonly reported sequence is Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe, with formula Cβ‚‡β‚ˆH₁₂₃N₂₃O₂₃Sβ‚‚ and average molecular mass approximately 1,815.1 Da. Pharma Research .eu presents this 5 mg format with 3 mL bacteriostatic water for qualified European laboratories.pubchem.ncbi.nlm.nih+2

Uncompromising Purity and Analytical Characterisation

AOD-9604 should be specified as:

H-Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-OH

The two cysteine residues form an intramolecular disulphide bridge. This oxidised structure is essential to the compound’s identity and should be confirmed analytically. Reduced peptide, intermolecular disulphide species and scrambled disulphide isomers have different molecular and chromatographic properties and should be reported as separate species.

For laboratory procurement, the suitable target is β‰₯99.0% purity by RP-HPLC, subject to confirmation by the actual batch-specific certificate of analysis. Because HPLC purity alone does not fully demonstrate disulphide integrity, the CoA should also include mass-spectral identity and, where relevant, oxidation-state or reduction-control data.evolvepeptides+1

A complete CoA should include:

  • RP-HPLC purity percentage, analytical method and chromatogram.

  • LC-MS, ESI-MS or high-resolution MS identity confirmation.

  • Sequence and disulphide-bridge designation.

  • Confirmation of the intended oxidised form.

  • Molecular formula and molecular-mass assignment.

  • Free-peptide, acetate or other salt-form information.

  • Visual appearance of the lyophilised material.

  • Residual-solvent results from synthesis and purification.

  • Water or residual-moisture content, where measured.

  • Heavy-metal or elemental-impurity results where included in the quality programme.

  • Lot number, manufacture date, retest date and storage requirements.

The commonly reported formula is Cβ‚‡β‚ˆH₁₂₃N₂₃O₂₃Sβ‚‚, with average molecular mass approximately 1,815.1 g/mol and monoisotopic mass near 1,813.86 Da. CAS Registry Number 221231-10-3 is widely reported, although some catalogues list an additional registry number; the supplier should reconcile the exact form on the CoA.pubchem.ncbi.nlm.nih+2

AOD-9604 is generally supplied as a white to off-white lyophilised powder. Visual inspection can identify gross discolouration, vial damage or visible contamination, but cannot establish identity or disulphide integrity. Analytical release should combine appearance assessment with RP-HPLC, mass spectrometry and appropriate reduction/oxidation controls.

High purity is essential because reduced thiols, disulphide-scrambled species, intermolecular aggregates, truncated chains and oxidation products can affect conformation, solubility and assay response. The N-terminal tyrosine may also contribute to light sensitivity. Lower-grade material may be unsuitable for quantitative LC-MS, structure-sensitive assays or reproducible in vitro comparisons.

Bacteriostatic water is a separate reagent and should have its own label, expiry date, preservative information and documentation. Its pH, preservatives and dissolved gases may influence disulphide stability and peptide recovery.

Principal Laboratory Applications and Research Methodologies

AOD-9604 is suitable for controlled laboratory research involving disulphide-peptide chemistry, analytical characterisation and in vitro biochemical or cellular model development. All applications should be conducted by qualified personnel within an appropriately governed university, CRO, pharmaceutical R&D or analytical laboratory.

Disulphide identity and stability studies. Laboratories may assess intact mass, oxidation state, reduction behaviour and disulphide scrambling using LC-MS, RP-HPLC and validated reduction controls. These studies are important because oxidised and reduced forms are chemically distinct.

RP-HPLC and LC-MS method development. AOD-9604 can support retention-time assignment, impurity profiling, precursor-ion selection and product-ion optimisation. Methods should resolve intact disulphide peptide from reduced, scrambled, truncated and aggregated species.

In vitro biochemical and cellular models. A verified lot may be incorporated into controlled cell-free or cellular systems examining peptide-associated biochemical pathways. Appropriate controls may include vehicle, matrix and reduced-peptide controls, depending on the research question.

Formulation and storage research. Laboratories may evaluate the influence of pH, temperature, light, oxygen, reducing agents, container material and freeze–thaw exposure. Both peptide content and disulphide integrity should be monitored.

The 5 mg quantity corresponds to approximately 2.75 Β΅mol using the reported molecular mass of 1,815.1 g/mol. If the complete quantity were dissolved in 3 mL, the nominal concentration would be approximately 1.67 mg/mL, or about 0.916 mM, before correction for purity, salt form, water content and final volume.

These calculations are for laboratory formulation planning only. The actual concentration should be based on the batch CoA and validated preparation method. Bacteriostatic water should be evaluated for compatibility with the peptide and selected assay, with suitable solvent blanks and disulphide-integrity controls.

Compound Stability, Optimal Storage, and Safe Handling Protocols

The lyophilised peptide should remain sealed, dry and protected from light until required for a validated laboratory procedure. Research guidance commonly recommends storage at approximately βˆ’20Β°C, with βˆ’80Β°C used for extended storage where supported by stability data.americanpeptides+2

Recommended controls include:

  • Store unopened lyophilised AOD-9604 at βˆ’20Β°C unless the CoA specifies otherwise.

  • Consider βˆ’80Β°C for extended archival storage where supported by the stability programme.

  • Keep the vial tightly closed, dry and protected from direct light.

  • Allow a sealed vial to reach room temperature before opening to minimise condensation.

  • Use low-binding, non-reactive containers where adsorption or thiol exchange could affect recovery.

  • Avoid reducing agents and unvalidated metal-containing buffers.

  • Prepare aliquots if repeated access is expected.

  • Store short-term aqueous solutions at 2–8Β°C only where validated.

  • Avoid repeated freeze–thaw cycles.

  • Monitor both peptide concentration and disulphide state during stability studies.

  • Record solvent, pH, concentration, preparation date, operator and storage history.

The cysteine residues make redox conditions particularly important. Reducing agents, dissolved oxygen, pH and trace metals can affect the disulphide bridge. Fixed post-reconstitution stability periods should not be claimed without product-specific data; published commercial guidance varies from approximately 7–21 days refrigerated to longer periods under validated conditions.pureuspeptide+1

Reconstitution should be performed using a validated laboratory procedure. Add the bacteriostatic water gradually, allow the powder to hydrate and mix gently. Avoid vigorous agitation and unvalidated reducing or chelating conditions. If turbidity, precipitation or an unexpected colour change occurs, assess the material analytically before use.

Handling should follow the current SDS and institutional chemical-risk assessment. Appropriate precautions generally include a certified fume hood or suitable local containment, nitrile gloves, safety goggles and a laboratory coat. Avoid aerosol generation and direct contact with the powder or solution. Dispose of peptide-containing materials through approved institutional chemical and laboratory-waste procedures.

Technical Specifications and Molecular Attributes

Attribute Specification
Product AOD-9604, 5 mg, supplied with 3 mL bacteriostatic water
Common designation AOD-9604; Tyr-hGH fragment analogue
Sequence H-YLRIVQCRSVEGSCGF-OH
Structural feature Intramolecular disulphide bridge between the two cysteine residues
Residue count 16 amino acids
IUPAC name Full systematic peptide name should be confirmed on the CoA; sequence notation is preferred for procurement
CAS Registry Number 221231-10-3 is widely reported; verify the exact form on the CoA
Molecular formula Cβ‚‡β‚ˆH₁₂₃N₂₃O₂₃Sβ‚‚
Average molecular mass Approximately 1,815.1 g/mol
Monoisotopic mass Approximately 1,813.86 Da
Physical state and colour Lyophilised white to off-white powder
Solubility profile Aqueous compatibility may be feasible; pH, redox conditions and buffer composition require validation
Typical purity Proposed target β‰₯99.0% by RP-HPLC; verify the actual lot-specific result
Identity testing LC-MS, RP-HPLC and disulphide-state assessment
Companion reagent 3 mL bacteriostatic water
Long-term storage Typically βˆ’20Β°C or βˆ’80Β°C, sealed and protected from light and moisture

The sequence, formula, disulphide structure, molecular mass and CAS number are supported by public chemistry and research references. Alternate registry numbers or formulae should be reconciled with the exact sequence and batch CoA before procurement.pubchem.ncbi.nlm.nih+3

Pharma Research .eu: Your Premier EU Vendor for High-Purity Reagents

Pharma Research .eu can position AOD-9604 as a documented European disulphide-peptide reagent for analytical chemists, biochemists and laboratory managers. The product file should include a batch-specific CoA, SDS, sequence, disulphide-state information, purity result, identity data, salt-form information and storage instructions for both the peptide and bacteriostatic water.

Any claim that Pharma Research .eu operates an ISO 9001-certified quality-management system should be supported by a current certificate identifying the issuing body, scope and validity. Claims concerning discreet or temperature-controlled logistics across EU member states should likewise be verified for the destination, carrier route, packaging and applicable transport requirements.

A quality-focused supplier should be able to discuss:

  • The YLRIVQCRSVEGSCGF sequence.

  • Intramolecular disulphide-bridge confirmation.

  • Oxidised versus reduced peptide testing.

  • RP-HPLC purity and LC-MS identity testing.

  • Residual solvents, moisture and elemental-impurity reporting.

  • Redox, buffer and container compatibility.

  • Storage, transport and documentation requirements.

Pharma Research .eu should therefore be described as a potential European source for research-grade AOD-9604, with vendor-specific certification and logistics claims verified through current records. The material is intended strictly for controlled laboratory research and analytical use by qualified personnel under applicable institutional procedures.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Buy AOD 9604 5 mg + bacteriostatic water 3 ml”

Your email address will not be published. Required fields are marked *

Shipping & Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisqueΒ vestibulum amet elit ut volutpat.